Adjuvant Chemotherapy for Elderly Patients with Gastric Cancer after D2 Gastrectomy

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Jin, Ying ^a   Qiu, Miao zhen ^a   Wang, De shen ^a   Zhang, Dong sheng ^a   Ren, Chao ^a   Bai, Long ^a   Luo, Hui yan ^a   Wang, Zhi qiang ^a   Wang, Feng hua ^a   Li, Yu hong ^a   Xu, Rui hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROPYRIMIDINE; FOLINIC ACID; LOBAPLATIN; MITOMYCIN; OXALIPLATIN; PACLITAXEL; PLATINUM COMPLEX;

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; D2 GASTRECTOMY; FEMALE; GASTRECTOMY; GERIATRIC PATIENT; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; GASTRECTOMY; HUMANS; MALE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 84872843548     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053149     Document Type: Article

References (24)

1. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, et al. (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11: 837-843.
2. Paoletti X, Oba K, Burzykowski T, Michiels S, Ohashi Y, et al. (2010) Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 303: 1729-1737.
3. Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, et al. (2002) Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 88: 21-27.
4. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730.
5. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, et al. (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20.
6. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, et al. (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 379: 315-321.
7. Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, et al. (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29: 4387-4393.
8. Saif MW, Makrilia N, Zalonis A, Merikas M, Syrigos K, (2010) Gastric cancer in the elderly: an overview. Eur J Surg Oncol 36: 709-717.
9. Goodwin JS, Hunt WC, Samet JM, (1993) Determinants of cancer therapy in elderly patients. Cancer 72: 594-601.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR, (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373-383.
11. Cohen SM, Neugut AI, (2004) Adjuvant therapy for rectal cancer in the elderly. Drugs Aging 21: 437-451.
12. Bouvier A-M, Jooste V, Bonnetain F, Cottet V, Bizollon M-H, et al. (2008) Adjuvant treatments do not alter the quality of life in elderly patients with colorectal cancer. Cancer 113: 879-886.
13. Barthelemy P, Heitz D, Mathelin C, Polesi H, Asmane I, et al. (2011) Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals. Crit Rev Oncol Hematol 79: 196-204.
14. Samet J, Hunt WC, Key C, Humble CG, Goodwin JS, (1986) Choice of cancer therapy varies with age of patient. JAMA 255: 3385-3390.
15. Sakuramoto S, Yamashita K, Watanabe M, (2009) Newly emerging standard chemotherapies for gastric cancer and clinical potential in elderly patients. World J Gastrointest Oncol 1: 47-54.
16. Dudeja V, Habermann EB, Zhong W, Tuttle TM, Vickers SM, et al. (2011) Guideline recommended gastric cancer care in the elderly: insights into the applicability of cancer trials to real world. Ann Surg Oncol 18: 26-33.
17. Hoffman KE, Neville BA, Mamon HJ, Kachnic LA, Katz MS, et al. (2012) Adjuvant therapy for elderly patients with resected gastric adenocarcinoma: population-based practices and treatment effectiveness. Cancer 118: 248-257.
18. Strauss J, Hershman DL, Buono D, McBride R, Clark-Garvey S, et al. (2010) Use of Adjuvant 5-Fluorouracil and Radiation Therapy After Gastric Cancer Resection Among the Elderly and Impact on Survival. International Journal of Radiation Oncology*Biology*Physics 76: 1404-1412.
19. Yu CC, Levison DA, Dunn JA, Ward LC, Demonakou M, et al. (1995) Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer 71: 1106-1110.
20. Msika S, Benhamiche AM, Jouve JL, Rat P, Faivre J, (2000) Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 36: 390-396.
21. Zhao SL, Fang JY, (2008) The role of postoperative adjuvant chemotherapy following curative resection for gastric cancer: a meta-analysis. Cancer Invest 26: 317-325.
22. Liu TS, Wang Y, Chen SY, Sun YH, (2008) An updated meta-analysis of adjuvant chemotherapy after curative resection for gastric cancer. Eur J Surg Oncol 34: 1208-1216.
23. Dittmar Y, Rauchfuss F, Gotz M, Scheuerlein H, Jandt K, et al. (2012) Impact of clinical and pathohistological characteristics on the incidence of recurrence and survival in elderly patients with gastric cancer. World journal of surgery 36: 338-345.
24. Kim JP, Lee JH, Kim SJ, Yu HJ, Yang HK, (1998) Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer 1: 125-133.